ADARx Pharmaceuticals, Inc. - duplicate
- Biotech or pharma, therapeutic R&D
Clinical stage biotechnology company developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies.



